Analysis originally distributed on May 23, 2018 By: Michael Vodicka of Cannabis Stock Trades
Back in January 2018, California legalized recreational cannabis. It was a huge breakthrough for the US cannabis industry and it sent cannabis stocks operating in California soaring.
For example, Innovative Industrial Properties (IIPR), a US cannabis company headquartered in San Diego California, jumped almost 100% in the month leading up to California going legal. Shareholders were rewarded with some big gains in a short time.
Today – I see this same pattern repeating itself on the other side of the country.
Massachusetts is set to legalize recreational cannabis on July 1 – a little more than a month away.
According to market-research firm New Frontier Data, sales should be around $500 million in 2018 and jump to more than $1 billion by 2020. Continue reading "Massachusetts Set To Legalize Cannabis"
Analysis originally distributed on February 28, 2018 By: Michael Vodicka of Cannabis Stock Trades
Back in June of 2017, the Toronto Stock Exchange recorded its largest Canadian cannabis IPO ever.
The event generated a lot of attention for the company going public and the broader cannabis sector.
Not all of it was positive. In fact, there were plenty of bearish headlines in the financial media.
Despite the bearish headlines, Cannabis Stocks Trades saw the long-term potential and added shares to our model portfolio in early June.
Nine months later, shares of Medreleaf (LEAF) are up 158% - even after a recent pullback. Continue reading "Record Canadian Cannabis IPO In 11 Days"
Analysis originally distributed on January 24, 2018 By: Michael Vodicka of Cannabis Stock Trades
There are fewer things that can send a stock soaring like a buyout. And right now - I see a wave of buyouts ready to pop off in the cannabis sector - and I want to show you how you can profit.
When one company buys another company - shares of the company being bought usually surge higher.
Let me give you a recent example.
On January 18, Celgene Corp. (CELG) announced it would buy Juno Therapeutics (JUNO), a promising young biotech for $85 per share - a 91% premium to its share price at the time of the announcement.
That sent shares of JUNO soaring 91% in just seven days - giving JUNO shareholders a big gain in a very short amount of time.
Today - I see a big wave of buyouts coming down the pike in the cannabis sector and I believe it is creating another awesome opportunity for big profits. Continue reading "7 Canadian Cannabis Stocks that Could Soar"